Recent advances in cardio-oncology: a report from the 'Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019'.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
12 2019
Historique:
received: 18 10 2019
pubmed: 31 12 2019
medline: 14 7 2020
entrez: 30 12 2019
Statut: ppublish

Résumé

While anti-cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and targeted therapy, are constantly advancing, cardiovascular toxicity has become a major challenge for cardiologists and oncologists. This has led to an increasing demand of cardio-oncology units in Europe and a growing interest of clinicians and researchers. The Heart Failure 2019 meeting of the Heart Failure Association of the European Society of Cardiology in Athens has therefore created a scientific programme that included four dedicated sessions on the topic along with several additional lectures. The major points that were discussed at the congress included the implementation and delivery of a cardio-oncology service, the collaboration among cardio-oncology experts, and the risk stratification, prevention, and early recognition of cardiotoxicity. Furthermore, sessions addressed the numerous different anti-cancer therapies associated with cardiotoxic effects and provided guidance on how to treat cancer patients who develop cardiovascular disease before, during, and after treatment.

Identifiants

pubmed: 31884717
doi: 10.1002/ehf2.12551
pmc: PMC6989292
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1140-1148

Informations de copyright

© 2019 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Références

JCSM Clin Rep. 2018 Jul-Dec;3(2):
pubmed: 31134216
Circulation. 2016 Mar 15;133(11):1104-14
pubmed: 26976915
Cardiovasc Res. 2019 Apr 15;115(5):922-934
pubmed: 30768157
Eur J Heart Fail. 2019 Apr;21(4):529-535
pubmed: 30811091
J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):701-714
pubmed: 29582584
Eur Heart J. 2019 Jun 7;40(22):1756-1763
pubmed: 30085070
Eur J Heart Fail. 2017 Nov;19(11):1361-1378
pubmed: 28949064
Science. 2001 Jan 12;291(5502):319-22
pubmed: 11209085
Thromb Res. 2011 Apr;127(4):382-3
pubmed: 21056904
Cardiovasc Res. 2019 Apr 15;115(5):844-853
pubmed: 30715247
Lancet. 2018 Mar 10;391(10124):933
pubmed: 29536852
Curr Med Chem. 2018;25(11):1327-1339
pubmed: 28403786
J Am Coll Cardiol. 2014 Mar 4;63(8):809-16
pubmed: 24291281
ESC Heart Fail. 2017 Nov;4(4):448-457
pubmed: 28960880
Cardiovasc Ther. 2018 Aug;36(4):e12435
pubmed: 29771478
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):561-70
pubmed: 23535024
Coron Artery Dis. 2017 Jan;28(1):1-2
pubmed: 27776090
Circulation. 2015 Jun 2;131(22):1981-8
pubmed: 25948538
Eur J Heart Fail. 2017 Dec;19(12):1566-1568
pubmed: 29271591
Am J Cardiol. 2013 Dec 15;112(12):1980-4
pubmed: 24075281
Mayo Clin Proc. 2014 Sep;89(9):1287-306
pubmed: 25192616
J Am Coll Cardiol. 2017 May 16;69(19):2428-2445
pubmed: 28494980
Ann Oncol. 2012 Apr;23(4):897-902
pubmed: 21828361
J Am Coll Cardiol. 2014 Sep 30;64(13):1310-9
pubmed: 25257631
Circulation. 2019 May 28;139(22):2570-2584
pubmed: 30922063
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Eur J Heart Fail. 2017 Sep;19(9):1095-1104
pubmed: 28470962
ESC Heart Fail. 2018 Dec;5(6):1083-1091
pubmed: 30570223
ESC Heart Fail. 2017 Aug;4(3):259-265
pubmed: 28772046
Blood. 2015 Feb 5;125(6):901-6
pubmed: 25525119
Chemotherapy. 2018;63(6):315-320
pubmed: 30840967
Lancet Oncol. 2018 Sep;19(9):e447-e458
pubmed: 30191849
J Am Coll Cardiol. 2013 Jan 8;61(1):77-84
pubmed: 23199515
Eur J Heart Fail. 2018 Dec;20(12):1721-1731
pubmed: 30191649
Epidemiology. 2011 Nov;22(6):797-804
pubmed: 21881515
Eur J Heart Fail. 2018 Oct;20(10):1382-1384
pubmed: 29943887
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
Cardiology. 2006;105(3):188-94
pubmed: 16493196
Circulation. 2018 Aug 14;138(7):696-711
pubmed: 29348263
Circ Res. 2016 Mar 18;118(6):1008-20
pubmed: 26987914
Support Care Cancer. 2013 Jan;21(1):313-26
pubmed: 23142924
Eur J Heart Fail. 2018 May;20(5):898-906
pubmed: 29148208
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):53-59
pubmed: 28849630
Int J Hepatol. 2013;2013:815105
pubmed: 23970972
Int J Cardiol. 2019 Oct 1;292:248-252
pubmed: 31006597
J Pain Symptom Manage. 2016 Jun;51(6):1091-1102.e4
pubmed: 27017920
J Clin Oncol. 2001 Jul 1;19(13):3163-72
pubmed: 11432882
Eur J Heart Fail. 2016 Dec;18(12):1524-1534
pubmed: 27910284
J Am Coll Cardiol. 2017 Nov 14;70(20):2536-2551
pubmed: 29145954
Expert Rev Mol Diagn. 2017 Mar;17(3):245-256
pubmed: 28092472
Front Physiol. 2018 Apr 11;9:382
pubmed: 29695980
Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):474-486
pubmed: 28330818
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
PLoS One. 2018 Mar 2;13(3):e0193753
pubmed: 29499053
Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):487-495
pubmed: 28189542
Ann Gastroenterol. 2012;25(2):106-118
pubmed: 24713845
Acta Oncol. 2016 Jun;55(6):659-63
pubmed: 27142228
Cell. 2019 Jul 11;178(2):346-360.e24
pubmed: 31257026
J Natl Cancer Inst. 2010 Jan 6;102(1):14-25
pubmed: 20007921
Support Care Cancer. 2017 Aug;25(8):2463-2473
pubmed: 28275898
Cancer. 2003 Jun 1;97(11):2869-79
pubmed: 12767102
J Am Soc Echocardiogr. 2014 Sep;27(9):911-39
pubmed: 25172399
Am J Hematol. 2017 Dec;92(12):1362-1369
pubmed: 28940587
Ann Clin Lab Sci. 2017 Mar;47(2):115-119
pubmed: 28442511
Oncologist. 2018 Jun;23(6):637-638
pubmed: 29666299
Circ Cardiovasc Imaging. 2012 Sep 1;5(5):596-603
pubmed: 22744937
Circulation. 2018 Aug 14;138(7):735-742
pubmed: 30359132
Infect Dis Ther. 2017 Mar;6(1):69-83
pubmed: 28160269
JACC Cardiovasc Imaging. 2018 Aug;11(8):1098-1105
pubmed: 29909105
Adv Exp Med Biol. 2017;1000:103-129
pubmed: 29098619
Cardiovasc Res. 2019 Apr 15;115(5):854-868
pubmed: 30715219
J Am Coll Cardiol. 2014 Mar 18;63(10):945-53
pubmed: 24361314
Stroke. 2011 Sep;42(9):2410-8
pubmed: 21817150
J Nephrol. 2010 May-Jun;23(3):253-62
pubmed: 20349418
ESC Heart Fail. 2017 May;4(2):81-87
pubmed: 28451443
Eur J Heart Fail. 2018 Feb;20(2):295-303
pubmed: 28872259
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):623-629
pubmed: 28639432
J Clin Oncol. 2012 Oct 20;30(30):3657-64
pubmed: 23008297
Am J Nephrol. 2011;33(2):121-30
pubmed: 21242672
J Natl Compr Canc Netw. 2012 May;10(5):628-53
pubmed: 22570293
Eur J Heart Fail. 2018 Dec;20(12):1732-1734
pubmed: 30328667
Eur J Heart Fail. 2019 Dec;21(12):1515-1525
pubmed: 31321851
Eur J Prev Cardiol. 2019 Feb;26(3):305-315
pubmed: 30376366
Am J Hematol. 2014 Feb;89(2):203-12
pubmed: 24532336
Lancet Oncol. 2018 Nov;19(11):1480-1492
pubmed: 30361170
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10436-41
pubmed: 27582470
J Am Soc Echocardiogr. 2017 Nov;30(11):1049-1058
pubmed: 28916243
J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):40-47
pubmed: 27897393
JACC Cardiovasc Imaging. 2018 Aug;11(8):1059-1068
pubmed: 29550306
Science. 2015 Apr 3;348(6230):62-8
pubmed: 25838374
Lancet Oncol. 2015 Mar;16(3):257-65
pubmed: 25704439
Lancet. 2017 Oct 21;390(10105):1833-1842
pubmed: 28855077
Breast Cancer Res Treat. 2016 Sep;159(2):375-84
pubmed: 27544225
ESC Heart Fail. 2019 Dec;6(6):1140-1148
pubmed: 31884717
Circulation. 2019 May 21;139(21):e997-e1012
pubmed: 30955352
ESC Heart Fail. 2018 Dec;5(6):1092-1098
pubmed: 30570226
Clin Chem. 2005 Aug;51(8):1405-10
pubmed: 15932966
ESC Heart Fail. 2018 Dec;5(6):1108-1117
pubmed: 29984916
Eur J Cancer. 2017 Aug;81:56-65
pubmed: 28601706
Am J Cardiol. 2003 Jul 15;92(2):226-30
pubmed: 12860232

Auteurs

Markus S Anker (MS)

Division of Cardiology and Metabolism, Department of Cardiology, Charité and Berlin Institute of Health Center for Regenerative Therapies (BCRT) and DZHK (German Centre for Cardiovascular Research), partner site Berlin and Department of Cardiology, Charité Campus Benjamin Franklin, Berlin, Germany.

Sara Hadzibegovic (S)

Division of Cardiology and Metabolism, Department of Cardiology, Charité and Berlin Institute of Health Center for Regenerative Therapies (BCRT) and DZHK (German Centre for Cardiovascular Research), partner site Berlin and Department of Cardiology, Charité Campus Benjamin Franklin, Berlin, Germany.

Alessia Lena (A)

Division of Cardiology and Metabolism, Department of Cardiology, Charité and Berlin Institute of Health Center for Regenerative Therapies (BCRT) and DZHK (German Centre for Cardiovascular Research), partner site Berlin and Department of Cardiology, Charité Campus Benjamin Franklin, Berlin, Germany.

Yury Belenkov (Y)

Sechenov Medical University, Moscow, Russia.

Jutta Bergler-Klein (J)

Department of Cardiology, Medical University of Vienna, Vienna, Austria.

Rudolf A de Boer (RA)

Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Dimitrios Farmakis (D)

University of Cyprus Medical School, Nicosia, Cyprus.
Department of Cardiology, Cardio-Oncology Clinic, Heart Failure Unit, Athens University Hospital 'Attikon', National and Kapodistrian University of Athens, Athens, Greece.

Stephan von Haehling (S)

Department of Cardiology and Pneumology, Heart Center Göttingen, German Center for Cardiovascular Medicine (DZHK), University of Göttingen Medical Center, Georg-August-University, Göttingen, Germany.

Zaza Iakobishvili (Z)

Department of Community Cardiology, Clalit Health Fund, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Christoph Maack (C)

Comprehensive Heart Failure Center (CHFC), University Clinic Würzburg, Würzburg, Germany.

Radek Pudil (R)

1st Department of Medicine-Cardioangiology, Faculty of Medicine, University Hospital, Hradec Králové, Czech Republic.

Hadi Skouri (H)

Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Alain Cohen-Solal (A)

Department of Cardiology, Lariboisière Hospital and U942 INSERM, BIOCANVAS (Biomarqueurs Cardiovasculaires), Paris University, Paris, France.

Carlo G Tocchetti (CG)

Department of Translational Medical Sciences and Interdepartmental Center for Clinical and Translational Sciences (CIRCET), Federico II University, Naples, Italy.

Andrew J S Coats (AJS)

IRCCS San Raffaele, Rome, Italy.

Petar M Seferović (PM)

Faculty of Medicine and Heart Failure Center, Belgrade University Medical Center, University of Belgrade, Belgrade, Serbia.

Alexander R Lyon (AR)

Royal Brompton Hospital and Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH